WCN26-8231 HEALTH STATUS IN KIDNEY REPLACEMENT THERAPY: A SUBGROUP ANALYSIS OF THE CONVINCE RANDOMIZED CONTROLLED TRIALKrister Cromm, Matthias Rose, N. L. Pham et al.|Kidney International Reports|2026Cited by 0
WCN26-8232 PROMIS-29 AS A VALID AND COMPARABLE PATIENT-REPORTED OUTCOME MEASURE TO THE SF-36 IN TURKISH DIALYSIS PATIENTSN. L. Pham, Hayriye Elbi, Krister Cromm et al.|Kidney International Reports|2026Cited by 0
WCN26-2809 CONVECTIVE VOLUME, PATIENT ANTHROPOMETRIC CHARACTERISTICS AND RISK OF ALL-CAUSE MORTALITY IN HEMODIAFILTRATION: A COHORT STUDYKrister Cromm, G. Strippoli, R W M Vernooij et al.|Kidney International Reports|2026Cited by 0
WCN26-1911 PATIENT-REPORTED INTER- AND INTRADIALYTIC SYMPTOMS IN HEMODIALYSIS AND HEMODIAFILTRATION PATIENTS - ANALYSIS FROM THE CONVINCE TRIALNgoc Pham Pham, G. Strippoli, Krister Cromm et al.|Kidney International Reports|2026Cited by 0
WCN26-8234 SELF-EFFICACY PREDICTS PROMIS HEALTH-RELATED QUALITY OF LIFE OUTCOMES IN TURKISH DIALYSIS PATIENTS BETTER THAN SF-36Krister Cromm, Hayriye Elbi, Özlem Kuman Tunçel et al.|Kidney International Reports|2026Cited by 0